Teva's Worst Week of 2018 Prompts Goldman to Defend Stock

(Bloomberg) -- Teva Pharmaceutical Industries Ltd had its worst week this year after two analysts cautioned on the generic drugmaker -- but Goldman Sachs is doubling down.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.